NCT06397443 2025-03-21
PaS
Istituto Ortopedico Rizzoli
Phase NA Completed
Istituto Ortopedico Rizzoli
FDA Office of Orphan Products Development
FDA Office of Orphan Products Development
FDA Office of Orphan Products Development
Office of Rare Diseases (ORD)
Office of Rare Diseases (ORD)